916 related articles for article (PubMed ID: 25561520)
1. Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures.
Myrick LK; Deng PY; Hashimoto H; Oh YM; Cho Y; Poidevin MJ; Suhl JA; Visootsak J; Cavalli V; Jin P; Cheng X; Warren ST; Klyachko VA
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):949-56. PubMed ID: 25561520
[TBL] [Abstract][Full Text] [Related]
2. Genetic upregulation of BK channel activity normalizes multiple synaptic and circuit defects in a mouse model of fragile X syndrome.
Deng PY; Klyachko VA
J Physiol; 2016 Jan; 594(1):83-97. PubMed ID: 26427907
[TBL] [Abstract][Full Text] [Related]
3. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
[TBL] [Abstract][Full Text] [Related]
4. Voltage-Independent SK-Channel Dysfunction Causes Neuronal Hyperexcitability in the Hippocampus of
Deng PY; Carlin D; Oh YM; Myrick LK; Warren ST; Cavalli V; Klyachko VA
J Neurosci; 2019 Jan; 39(1):28-43. PubMed ID: 30389838
[TBL] [Abstract][Full Text] [Related]
5. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
[TBL] [Abstract][Full Text] [Related]
6. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
[TBL] [Abstract][Full Text] [Related]
8. Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNAs in mouse.
Filippini A; Bonini D; Lacoux C; Pacini L; Zingariello M; Sancillo L; Bosisio D; Salvi V; Mingardi J; La Via L; Zalfa F; Bagni C; Barbon A
RNA Biol; 2017 Nov; 14(11):1580-1591. PubMed ID: 28640668
[TBL] [Abstract][Full Text] [Related]
9. Expression of fragile X mental retardation-1 gene with nuclear export signal mutation changes the expression profiling of mouse cerebella immortal neuronal cell.
Hu L; Chen Y; Evers S; Shen Y
Proteomics; 2005 Oct; 5(15):3979-90. PubMed ID: 16130171
[TBL] [Abstract][Full Text] [Related]
10. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
[TBL] [Abstract][Full Text] [Related]
11. A novel fragile X syndrome mutation reveals a conserved role for the carboxy-terminus in FMRP localization and function.
Okray Z; de Esch CE; Van Esch H; Devriendt K; Claeys A; Yan J; Verbeeck J; Froyen G; Willemsen R; de Vrij FM; Hassan BA
EMBO Mol Med; 2015 Apr; 7(4):423-37. PubMed ID: 25693964
[TBL] [Abstract][Full Text] [Related]
12. Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats.
Ruby K; Falvey K; Kulesza RJ
Neuroscience; 2015 Sep; 303():285-98. PubMed ID: 26166728
[TBL] [Abstract][Full Text] [Related]
13. FMRP Sustains Presynaptic Function via Control of Activity-Dependent Bulk Endocytosis.
Bonnycastle K; Kind PC; Cousin MA
J Neurosci; 2022 Feb; 42(8):1618-1628. PubMed ID: 34996816
[TBL] [Abstract][Full Text] [Related]
14. The fragile X syndrome: exploring its molecular basis and seeking a treatment.
Bardoni B; Davidovic L; Bensaid M; Khandjian EW
Expert Rev Mol Med; 2006 Apr; 8(8):1-16. PubMed ID: 16626504
[TBL] [Abstract][Full Text] [Related]
15. Fragile X syndrome: From protein function to therapy.
Bagni C; Oostra BA
Am J Med Genet A; 2013 Nov; 161A(11):2809-21. PubMed ID: 24115651
[TBL] [Abstract][Full Text] [Related]
16. STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice.
Chatterjee M; Kurup PK; Lundbye CJ; Hugger Toft AK; Kwon J; Benedict J; Kamceva M; Banke TG; Lombroso PJ
Neuropharmacology; 2018 Jan; 128():43-53. PubMed ID: 28943283
[TBL] [Abstract][Full Text] [Related]
17. Fragile X Syndrome: from molecular pathology to therapy.
Maurin T; Zongaro S; Bardoni B
Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():242-55. PubMed ID: 24462888
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of fragile X syndrome: a twenty-year perspective.
Santoro MR; Bray SM; Warren ST
Annu Rev Pathol; 2012; 7():219-45. PubMed ID: 22017584
[TBL] [Abstract][Full Text] [Related]
19. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome.
Gray EE; Murphy JG; Liu Y; Trang I; Tabor GT; Lin L; Hoffman DA
J Neurosci; 2019 Sep; 39(38):7453-7464. PubMed ID: 31350260
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
